# The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus Erythematosus

> **NCT00797784** · PHASE2 · UNKNOWN · sponsor: **Florida Academic Dermatology Centers** · enrollment: 20 (estimated)

## Conditions studied

- Discoid Lupus Erythematosus (DLE)

## Interventions

- **DRUG:** etanercept(Enbrel®)

## Key facts

- **NCT ID:** NCT00797784
- **Lead sponsor:** Florida Academic Dermatology Centers
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-10
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2010-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00797784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00797784, "The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus Erythematosus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00797784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*